2020 American Transplant Congress » Poster Session A: Biomarkers, Immune Assessment and Clinical Outcomes

3:30pm-4:00pm

A Two-Step Cell-Based Assay Predicts Immunosuppression-Related Adverse Events in Kidney Transplant Recipients

F. Bouchard-Boivin, O. Désy, S. Béland, S. De Serres

3:30pm-4:00pm

Age- and Sex-Mediated Differences in T Lymphocyte Populations of Kidney Transplant Recipients

R. Dziarmaga¹, D. Ke¹, V. Phan², H. Cardinal³, R. Sapir-Pichhadze¹, C. A. Piccirillo¹, B. Mazer¹, B. Foster¹

3:30pm-4:00pm

Automatic Quantification of Interstitial Fibrosis in Renal Allograft

J. Hogan¹, J. Vizcarra², M. A. Tageldin², L. A. Cooper³, D. A. Gutman², A. B. Farris⁴

3:30pm-4:00pm

Chronic Diarrhea in Renal Transplant Recipients: A Metagenomic Study of Gut Microbiota Composition and Functionality

J. C. Swarte¹, R. M. Douwes¹, S. Hu², R. Gacesa², H. J. Harmsen³, R. K. Weersma², S. J. Bakker¹

3:30pm-4:00pm

Clinical Relevance of Immunoglobulin M Deposition in Peritubular Capillaries in ABO-Incompatible Kidney Transplantation

D. Toki¹, M. Okumi², K. Unagami², Y. Kakuta², H. Ishida², K. Yamashita¹, H. Tachibana¹, A. Hayashida¹, T. Horiuchi¹, Y. Ishiyama¹, K. Honda³, T. Kondo¹, K. Tanabe²

3:30pm-4:00pm

Combined Phenotyping to Identify Kidney Transplants at Greatest Risk after Subclinical Acute Rejection

S. Park¹, R. Heilman², E. Poggio³, D. Taber⁴, L. Zhao¹, K. Guo¹, S. Kurian⁵, C. Rebello¹, S. Brietigam¹, M. Abecassis⁶, J. Friedewald¹

3:30pm-4:00pm

Complement Activation and Delayed Graft Function after Kidney Transplantation

C. Arias-Cabrales¹, M. Pérez-Sáez¹, M. Riera¹, J. Gimeno², D. Benito¹, D. Redondo-Pachón¹, A. Buxeda¹, C. Burballa¹, M. Crespo¹, J. Pascual¹, E. Rodríguez¹

3:30pm-4:00pm

Does Pretransplant C-Peptide Influence Outcomes Following Simultaneous Pancreas-Kidney Transplantation: A Case-Control Study

V. Gurram, K. Gurung, J. Rogers, A. Farney, G. Orlando, C. Jay, A. Reeves-Daniel, A. Mena-Gutierrez, N. Sakhovskaya, W. Doares, S. Kaczmorski, M. Gautreaux, R. Stratta

3:30pm-4:00pm

Donor-Derived Cell-Free DNA Combined with Histology Improves Prediction of eGFR Decline in Kidney Transplant Recipients over Histology Alone

M. Gillespie, M. Haas, K. Lim, A. Vo, A. Peng, R. Najjar, S. Sethi, S. Jordan, E. Huang

3:30pm-4:00pm

Donor-Specific B Cell Frequency Assessed by a Novel Multiplex Bead-Based Assay Predicts Graft Failure in Kidney Transplant Recipients

Z. Ilyas, A. Akl, D. Pinelli, L. Gallon, A. R. Tambur, M. Ansari

3:30pm-4:00pm

HLA-DQ Plays an Important Role in Graft Survival in African American Transplant Recipients

L. M. Rebellato¹, W. Irish², D. Leeser², J. Tuttle², C. E. Haisch²

3:30pm-4:00pm

Hepatocyte Growth Factor (HGF) Prevents the Apoptotic and Anti-Angiogenic Effect of Hypercholesterolemia on Hepatocytes in Liver Allografts

H. B. Ozdemir¹, G. Ozgun¹, A. Yucel Polat¹, N. Haberal¹, G. Moray², M. Haberal²

3:30pm-4:00pm

Hif-1a Expression Influences Recipient Clinical Outcomes in Liver Transplant Patients

K. Kadono, T. Ito, H. Kojima, K. Nakamura, H. Hirao, S. Kageyama, K. J. Dery, A. Murray, R. W. Busutill, F. Kaldas, J. W. Kupiec-Weglinski

3:30pm-4:00pm

Identifying Factors Associated with Delayed Graft Function Severity Using the OPTN Database

K. Checchi¹, D. Stewart², A. Toll², J. Case¹, S. Kurian¹, C. Marsh¹

3:30pm-4:00pm

In Silico Deconvolution of Whole Blood RNA-Seq Data from Iscalimab Phase IIa Study in Renal Transplant Reveals Insights Into Mechanism of Action and Superiority of Iscalimab Compared to Tacrolimus

J. S. Rush

3:30pm-4:00pm

Persistent Fibrinolysis Shutdown in Liver Transplant Recipients is Associated with Early Allograph Dysfunction

H. B. Moore¹, T. Nydam¹, J. Pomposelli¹, C. Walker¹, A. Schulick¹, R. Choudhury¹, H. Yaffe¹, M. Adams², M. Cohen³, E. Pomfret¹

3:30pm-4:00pm

Prevalence and Predictors of Sensory Polyneuropathic Signs and Symptoms in Renal Transplant Recipients

S. Nolte¹, J. Hofman¹, A. Gomes-Neto¹, B. de Greef², J. Elting¹, M. Eisenga¹, M. van Londen¹, S. Bakker¹, I. Nolte¹, C. Faber², J. Sanders¹, D. Touw¹, I. Lesman-Leegte¹, S. Berger¹, G. Drost¹

3:30pm-4:00pm

Relapse-Prone Unresectable Hepatoblastoma (HB) Requiring Liver Transplantation (LT) Are Immunogenic and May Be Sensitive to Immune Checkpoint Inhibitors

M. Ningappa¹, C. Ashokkumar¹, J. Garifallou², M. Gonzalez², H. Hakonarson², S. Ranganathan¹, B. W. Higgs¹, R. Sindhi¹

3:30pm-4:00pm

Significance of Gene Polymorphism on Infectious Complications and Rejection after Liver Transplantation

H. Egawa¹, T. Kato¹, Y. Kotera¹, A. Ohmori¹, G. Shibuya¹, S. Yamashita¹, S. Ariizumi¹, M. Yamamoto¹, T. Ishizuka², Y. Tanaka³, H. Ohdan³

3:30pm-4:00pm

Single Center Experience in Using Donor-Derived Cell-Free DNA in Kidney Transplant

P. Homkrailas¹, S. Lee², B. Kandagedon¹, G. Danovitch¹, S. Bunnapradist¹

3:30pm-4:00pm

Time-Zero Histology Correlates with Donor Characteristics but Does Not Predict Short-Term Outcomes in Kidney Transplantation

S. Raza, G. Agarwal, D. Anderson, M. Deierhoi, H. Fatima, M. Hanaway, J. Locke, P. MacLennan, B. Orandi, C. Young, R. Mannon, M. Seifert

3:30pm-4:00pm

Torque Teno Virus Level for Risk Stratification of Subclinical Graft Rejection at 12 Months after Kidney Transplantation – An Prospective Observational Cohort Study

K. Doberer, E. Puchhammer, G. Böhmig, G. Bond

3:30pm-4:00pm

Transitional B Cell Cytokines for the Early Prediction of Long-Term Renal Allograft Decline

A. Cherukuri¹, A. Salama², A. Sharma¹, R. Mehta¹, S. Hariharan¹, D. Rothstein¹

3:30pm-4:00pm

Urinary CXCL10: From Diagnosis to Prediction of BK Viremia in Kidney Transplantation

C. Tinel¹, A. Vermorel¹, D. Picciotto¹, L. Morin¹, C. Legendre¹, M. Rabant², D. Anglicheau¹

3:30pm-4:00pm

Urinary Exosomal Hemopexin, a Validated Diagnostic Marker for Rejection in Kidney Transplant Recipients

J. Lee¹, J. Kim², G. Lee², S. Jeon², H. Noh², J. Lim², H. Jung², J. Choi², J. Cho², S. Park², Y. Kim², C. Kim²

3:30pm-4:00pm

Validity and Utility of Urinary CXCL10/Cr Monitoring in Pediatric Kidney Transplant Recipients

T. Blydt-Hansen¹, A. Sharma², I. Gibson², C. Weibe², A. Sharma³, V. Langlois⁴, C. Teoh⁴, D. Rush², P. Nickerson², D. Wishart⁵, J. Ho²

3:30pm-4:00pm

dd-cfDNA as a Risk Factor for Initiating De-Novo Donor Specific Antibodies in Heart Transplantation

E. DePasquale¹, J. Kobashigawa², S. Pinney³, K. Khush⁴